Related Experiment Video

Updated: May 25, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

[Anti-MDR tumor mechanism of CIP-36, a podophyllotoxin derivative]

Xin Mei1, Yun-gen Jiang, Jing-jing Lü

  • 1Department of Pharmacognosy, Medical College of Chinese People's Armed Police Forces, Tianjin 300162, China.

Yao Xue Xue Bao = Acta Pharmaceutica Sinica
|January 17, 2012
PubMed

Insights

CIP-36 demonstrates significant antitumor activity against multidrug-resistant oral cancer cells (KBV200). It induces apoptosis and modulates key genes involved in multidrug resistance, offering a potential therapeutic strategy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Multidrug resistance (MDR) in cancer poses a significant challenge to effective chemotherapy.
  • Oral squamous cell carcinoma (OSCC) often exhibits resistance to conventional treatments.
  • Identifying novel agents that can overcome MDR is crucial for improving patient outcomes.

Purpose of the Study:

  • To evaluate the in vitro antitumor effects of CIP-36 on multidrug-resistant human oral squamous carcinoma cells (KBV200).
  • To elucidate the potential anticancer mechanisms of CIP-36, focusing on apoptosis induction and modulation of MDR-related genes.

Main Methods:

  • Cell viability was assessed using MTT assay.
  • Apoptosis was detected via Hoechst 33342 staining.
  • Gene expression changes (p53, p21, caspase-3, bax, mdr-1, bcl-2) were analyzed by RT-PCR.
  • P-glycoprotein (P-gp) expression was evaluated using immunohistochemistry.

Main Results:

  • CIP-36 significantly inhibited the growth of KBV200 cells, particularly the multidrug-resistant ones.
  • Hoechst staining confirmed the induction of apoptosis by CIP-36.
  • RT-PCR revealed a dose-dependent increase in pro-apoptotic genes (p53, p21, caspase-3, bax) and a decrease in anti-apoptotic/MDR genes (mdr-1, bcl-2).
  • Immunohistochemistry showed a dose-dependent decrease in P-gp expression.

Conclusions:

  • CIP-36 exhibits potent antitumor activity against multidrug-resistant oral cancer cells.
  • CIP-36 effectively induces apoptosis and overcomes multidrug resistance.
  • The compound modulates key resistance-related genes and proteins, suggesting its potential as a therapeutic agent for MDR OSCC.

More Related Videos

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

Related Concept Videos

Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...